More about

Disease

News
October 30, 2019
2 min read
Save

IOP fluctuation may predict rate of visual field deterioration

Fluctuating IOP was a significant and independent predictor for subsequent visual field deterioration in patients with primary angle closure glaucoma, according to findings published in the British Journal of Ophthalmology.

News
September 19, 2019
3 min read
Save

Coming Soon: NASH Treatment Approaching the Horizon

Coming Soon: NASH Treatment Approaching the Horizon

Nonalcoholic steatohepatitis is an increasingly common cause of cirrhosis, hepatocellular carcinoma and liver-related mortality. Along its progression, severe nonalcoholic steatohepatitis includes the development of clinically significant or advanced fibrosis. Currently, there are no approved therapeutics to treat this disease, but that will be changing soon.

News
September 06, 2019
6 min read
Save

CDC: 5 deaths, more than 450 cases of pulmonary disease possibly linked to vaping

During a telebriefing today, CDC announced that 450 possible cases of pulmonary disease associated with e-cigarette use, including three confirmed deaths and one under investigation, have been reported in 33 states and one jurisdiction since June 2019.

News
September 06, 2019
11 min read
Save

New research, recent controversies question vitamin D benefits in CVD

New research, recent controversies question vitamin D benefits in CVD

The idea of “sunshine in a bottle” — vitamin D supplementation — has been promoted as a possible fix for everything from bone and immune system health to depression, dementia and diabetes, and the premise sells. It has also been investigated as a strategy for CVD prevention, but results to date have been negative.

News
September 03, 2019
2 min read
Save

Older age, peak IOP may speed glaucoma progression

Identifying and aggressively treating factors leading to fast progression of glaucoma may decrease the visual disability of the disease, according to findings published in the American Journal of Ophthalmology.

News
August 26, 2019
2 min read
Save

FDA expands Taltz approval for ankylosing spondylitis

FDA expands Taltz approval for ankylosing spondylitis

The FDA has extended approval for ixekizumab injection 80 mg/mL to treat adults with ankylosing spondylitis – or radiographic axial spondyloarthritis - according to an Eli Lilly press release.

News
August 15, 2019
2 min read
Save

Rheumatoid arthritis may start in the lungs rather than joints

Rheumatoid arthritis may start in the lungs rather than joints

ORLANDO — A line of progression from disease susceptibility to overt rheumatoid arthritis could potentially begin with environmental factors in the lungs, as well as the gingiva, according to a presenter at the 2019 Rheumatology Nurses Society Annual Conference.

News
August 09, 2019
7 min read
Save

Ovarian cancer: Is this the beginning of the end?

Ovarian cancer: Is this the beginning of the end?

There will be 22,530 new cases of ovarian cancer in the United States this year.

News
January 24, 2019
11 min read
Save

New research, recent controversies call vitamin D benefits into question

New research, recent controversies call vitamin D benefits into question

The idea of “sunshine in a bottle” — vitamin D supplementation — has been promoted as a possible fix for everything from bone and immune system health to depression, dementia and diabetes, and the premise sells. According to recent CDC statistics, approximately 45% of middle-aged women and 38% of middle-aged men report taking a vitamin D supplement, and hundreds of thousands of Americans get tested for vitamin D deficiency each year.

News
January 17, 2019
2 min read
Save

Rate of late-onset GBS in infants surpasses early-onset cases

Rate of late-onset GBS<i> </i>in infants surpasses early-onset cases

The rate of early-onset disease caused by group B Streptococcus, or GBS, has decreased among infants in the United States between 2006 and 2015, according to research published in JAMA Pediatrics. Researchers said late-onset disease caused by GBS is now more common in this population, which means efforts to prevent the disease should shift toward vaccine development rather than intrapartum antibiotic prophylaxis.

View more